CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Ashley McEvoy

Chief Executive Officer, President & Director, Insulet Corporation

Search every verified Ashley McEvoy interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Ashley McEvoy, President and Chief Executive Officer of Insulet Corporation, discussed the company’s third quarter 2026 results and outlook during a November 5, 2026 earnings call. She noted that Insulet anticipated closing out its 11th consecutive year of 20% revenue growth, citing strong trends in its global customer base, which increased by about 20%. McEvoy also mentioned that the company expected its growth rate to moderate in 2027, attributing the change to factors such as the strength of its existing base, market growth assumptions, competition, and difficult international comparisons. McEvoy highlighted recent operational actions, including the completion of Insulet’s second U.S. sales force expansion in two years, which increased its footprint by nearly 25%, and a new four-month certification program for field representatives. She also emphasized the company’s commitment to broad access for its Omnipod products, stating that Insulet has over 98% coverage, including strong Medicaid and Medicare coverage, and a leadership share in the pharmacy channel. Looking ahead, she described an innovation agenda beginning with Omnipod 6 and what she called the industry’s first fully closed-loop system, which she said could be transformative for type 2 diabetes care.

Recent appearances

  • Insulet Corporation Q3 2026 Earnings Call | Omnipod 5 Automated Insulin Delivery Uptake Climbs

    Insulet Corporation Q3 2026 Earnings Conference Call. Twitter - https://x.com/i101yt If you find our work useful, please support us by purchasing a Super Thanks— it truly helps us a lot. #earningscall #StockMarketNews #conferenceCall Earnings Call | Earnings Conference Call | Earnings concall | concall | quarterly results | Stock News | Full Year results | Fiscal Year results | investment news | stock latest news | Annual Meeting of Shareholders | Annual Meeting of Unitholders | Special and Annual Meeting of Shareholders | AGM | Annual General Meeting If you want us to remove your compan…

    Watch on YouTube ↗

  • Insulet Corp ($PODD) Q2 2026 Earnings Call

    Listen to the Insulet Corp ($PODD) Q2 2026 earnings call. This episode covers Insulet Corp quarterly results, revenue, EPS, business performance, guidance, outlook, management commentary, and investor Q&A. Participants: Clare Trachtman - VP of Investor Relations Ashley McEvoy - President and CEO Flavia Pease - EVP and CFO Eric Benjamin - EVP and COO Robbie Marcus - Analyst, J.P. Morgan Travis Steed - Analyst, Bank of America Larry Biegelsen - Analyst, Wells Fargo Jeff Johnson - Analyst, Baird Matt Taylor - Analyst, Jefferies Marie Thibault - Analyst, BTIG Richard Newitter - Analyst, Truist Se…

    Watch on YouTube ↗

  • Insulet Corporation Q4 2025 Earnings Call

    Insulet Corporation Q4 2025 Earnings Conference Call. If you find our work useful, please support us by purchasing a Super Thanks— it truly helps us a lot. #earningscall #StockMarketNews #conferenceCall Earnings Call | Earnings Conference Call | Earnings concall | concall | quarterly results | Stock News | Full Year results | Fiscal Year results | investment news | stock latest news If you want us to remove your company's earnings call or any other conference call, please reach out to [email protected].

    Watch on YouTube ↗

  • Insulet Investor Day 2025 | Nov 20, 2025

    Twitter -   / i101in   #earningscall #StockMarketNews If you want us to remove your company's earnings call or any other conference call, please reach out to [email protected].

    Watch on YouTube ↗

  • Where Does J&J See Growth in Ophthalmology? (OIS@AAO 2016)

    Interview from Healthegy's OIS@AAO 2016: Ashley McEvoy, company group chairman, Johnson & Johnson Vision Care, says ophthalmology remains a “really special” part of J&J’s future. The strategic sees eye care as one of the top five medical specialties and it intends to use the acquisition of Abbott Medical Optics and partnerships with Google to build an even more meaningful practice in the space. For more on Ophthalmology Innovation News & Events visit: http://ois.net/

    Watch on YouTube ↗

  • On-Sight Interview: Eye Care Priority for J&J (OIS@ASCRS 2016)

    Ashley McEvoy, Company Chair of Vision Care and Diabetes at Johnson & Johnson, joins OIS.TV to discuss Johnson & Johnson’s commitment to eye health. For more on Ophthalmology Innovation News & Events visit: http://ois.net/ Video Highlights: 00:49 – Emerging areas of interest: lung cancer, diabetes and eye health? 01:00 – What areas in eye care are you looking at? 01:25 – How does expertise in consumer health help J&J? 01:58 – How a multi-disciplinary approach helps innovate new technologies? 3:10 – We’re very bullish on eye health.

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →